Search results

Radionuclides in medicine

Radionuclides have been used routinely in medicine for more than 60 years. Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs to diagnose or treat disease. The radionuclides used in medicine have half-lives ranging from a few minutes to several days in order to minimise the radiation dose the patient receives. For three unknown medical radionuclides, students will graph their decay over time, use the graph to calculate their half-life, and determine the identify and use of each radionuclide using background information provided.

Radionuclides in medicine student worksheet and data set

Radionuclides in Medicine Student Worksheet 19-06-2020 numbers deleted.docx

Australian Nuclear Medicine Traceability Program (ANMTP)

The Australian Nuclear Medicine Traceability Program (ANMTP) assists practices administering nuclear medicine-based radionuclides to achieve regulatory compliance by providing measurement traceability to the Australian Standard.

Radioactivity Measurement

ANSTO has responsibilities mandated by the Australian Government for the maintenance of the national measurement standard for radioactivity.

Dr Freda van Wyngaardt

Radionuclide Metrology Scientist

Role at ANSTO

Radiation measurement

ANSTO maintains national capabilities in radionuclide metrology, the measurement and detection of ionising radiation, radioanalytical chemistry and nuclear forensics to support industry, government and scientific users.

Data sets

Your students can analyse real research data from ANSTO scientists.

Teacher Professional Development Courses

ANSTO is an experienced provider of Teacher Professional Development for Australian and International teachers and our courses cover a wide range of topics. Hear from expert speakers, receive new education resources, and develop lessons for your own class.

Radioisotopes

Using the OPAL multipurpose reactor,, ANSTO can provide a diverse suite of radioisotopes for research and applications

New Joint Venture to manufacture GMP theranostic radiopharmaceuticals in Australia

Cyclotek and ANSTO have announced the launch of a Joint Venture (JV), to establish Australia’s first GMP (Good Manufacturing Practice) theranostics facility starting in Melbourne, Australia.

Synroc: Australian innovation increases technology readiness for waste treatment plant

Carbon ion therapy research

ANSTO research focuses on an advanced form of cancer treatment under consideration in Australia.

Managing Radioactive Waste

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

The women of nuclear stewardship science are experts in the safe use of radioactivity

Microfluidics: the next wave of disruptive technology in radiochemistry?

Imaging technology has the ability to capture and display gamma radiation

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

Australia's nuclear credentials highly regarded internationally through ANSTO

Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.

Bringing radiochemistry to life

Gamma radiation imaging technology

A new imaging technology developed at ANSTO makes it possible to image, identify and locate gamma-ray radiation in a safe and timely manner.

Radionuclides in medicine student worksheet and data set

Role at ANSTO

Pagination